Triasima Portfolio Management Inc. Novartis Ag Transaction History
Triasima Portfolio Management Inc.
- $387 Million
- Q3 2024
A detailed history of Triasima Portfolio Management Inc. transactions in Novartis Ag stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 32,275 shares of NVS stock, worth $3.14 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
32,275
Previous 12,400
160.28%
Holding current value
$3.14 Million
Previous $1.32 Million
181.21%
% of portfolio
0.96%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$788 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$680 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$562 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...